'Superbugs' a far greater risk than Covid in Pacific, scientist warns
Antimicrobial resistance ‘biggest human health threat, bar none’, says Australian research director ahead of three-year study in FijiThe emergence ofantimicrobial resistance (AMR), including drug-resistant bacteria, or “superbugs”, pose far greater risks to human health than Covid-19, threatening to put modern medicine “back into the dark ages”,an Australian scientist has warned, ahead of a three-year study into drug-resistant bacteria in Fiji.“If you thought Covid was bad, you don’t want anti-microbial resistance,” Dr Paul De Barro, biosecurity research director at Aus...
Source: Guardian Unlimited Science - September 10, 2020 Category: Science Authors: Sheldon Chanel in Suva and Ben Doherty Pacific editor Tags: World news Coronavirus outbreak Infectious diseases Science Medical research Microbiology Fiji Pacific islands Asia Pacific Source Type: news

This'Slowly Evolving Crisis' Needs Attention This'Slowly Evolving Crisis' Needs Attention
Antimicrobial resistance, stewardship, and research and development must remain top of mind, says Dr Paul Auwaerter.Medscape Infectious Diseases (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - August 28, 2020 Category: Infectious Diseases Tags: Infectious Diseases Commentary Source Type: news

Evidence for action: a One Health learning platform on interventions to tackle antimicrobial resistance, The Lancet Infectious Diseases
Within efforts to strengthen global governance of antimicrobial resistance, this Personal view calls for the creation of a platform that will synthesise the evidence for actions on antimicrobial resistance into a fully accessible database, that generates new scientific insights. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 28, 2020 Category: Consumer Health News Source Type: news

Treating COVID-19 could lead to increased antimicrobial resistance
(University of Plymouth) Research led by the University of Plymouth suggests the increased use of antibiotics in the treatment of COVID-19 patients could be placing an additional burden on waste water treatment works, particularly those serving large or emergency hospitals (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 25, 2020 Category: International Medicine & Public Health Source Type: news

Study: Honey May Be Better At Treating Coughs, Colds Than Over-The-Counter Medicines
(CNN) — Honey may be a better treatment for coughs and colds than over-the-counter medicines, a new study has found. Researchers said honey was more effective in relieving the symptoms of cold and flu-like illnesses than the usual commercial remedies, and could provide a safer, cheaper and more readily available alternative to antibiotics. They encouraged doctors to consider recommending it to patients in place of prescribing antibiotics, which can cause side effects and lead to antibiotic resistance when overused. Honey has long been used as a home remedy for coughs, but its effectiveness in treating common illnesse...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - August 19, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Syndicated CBSN Boston CNN Source Type: news

C-CAMP kicks off programme for antimicrobial resistance innovations
The programme, which was announced at the Grand Finale of the C-CAMP AMR Quest held in July 2020, has been kicked off with six innovators in therapeutics and diagnostics. (Source: The Economic Times)
Source: The Economic Times - August 12, 2020 Category: Consumer Health News Source Type: news

House Begins Work on FY 2021 Appropriations
Over the past two weeks, the House Appropriations Committee has swiftly advanced all twelve appropriations bills for fiscal year (FY) 2021. These bills will now be considered by the full House of Representatives. The Commerce, Justice, and Science (CJS) spending measure would provide $8.55 billion to the National Science Foundation (NSF), which is $270 million increase from FY 2020. The President proposed a 6 percent cut for the science agency for FY 2021. Research and related activities within NSF, which includes the Biological Sciences Directorate, would receive grow by $230 million to $6.97 billion in FY 2021. Under t...
Source: Public Policy Reports - July 21, 2020 Category: Biology Authors: AIBS Source Type: news

Antimicrobial resistance is the next battle
Covid-19 is a warning that we must develop drugs to treat future threats (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - July 13, 2020 Category: Pharmaceuticals Source Type: news

New initiative to bridge the gap on antimicrobial innovation
Today, more than 20 leading biopharmaceutical companies are launching theAMR Action Fund, a ground-breaking partnership to invest nearly $1 billion to ensure a robust and diverse pipeline of new medicines to treat drug-resistant infections. (Source: The Catalyst)
Source: The Catalyst - July 9, 2020 Category: Pharmaceuticals Tags: Coronavirus Antimicrobial Resistance Source Type: news

Stop TB Partnership and Johnson & Johnson, with support from USAID and The Global Fund, Announce Price Reduction for SIRTURO ® (bedaquiline) for Treatment of Drug-Resistant Tuberculosis in Low- and Middle-Income Countries
GENEVA, SWITZERLAND, 6 JULY 2020 – The Stop TB Partnership and Johnson & Johnson – with support from the Global Fund to Fight AIDS, TB and Malaria, and the U.S. Agency for International Development (USAID) – today announced joint efforts to help enable low- and middle-income countries to rapidly scale up use of SIRTURO® (bedaquiline) 100mg tablets in support of new, recently-released World Health Organization (WHO) treatment guidelines. Effective immediately, Johnson & Johnson will make bedaquiline available to Stop TB Partnership’s Global Drug Facility (GDF) at a price of USD$340 per si...
Source: Johnson and Johnson - July 6, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Rethink Food Security and Nutrition Following Covid-19 Pandemic
By Jomo Kwame Sundaram and Wan Manan MudaKUALA LUMPUR, Malaysia, Jul 2 2020 (IPS) The Covid-19 crisis has had several unexpected effects, including renewed attention to food security concerns. Earlier understandings of food security in terms of production self-sufficiency have given way to importing supplies since late 20th century promotion of trade liberalization. Jomo Kwame SundaramTransnational food business Disruption of transnational food supply chains and the devastation of many vulnerable livelihoods by policy responses to the Covid-19 pandemic have revived interest in earlier understandings of food self-sufficien...
Source: IPS Inter Press Service - Health - July 2, 2020 Category: International Medicine & Public Health Authors: Jomo Kwame Sundaram and Wan Manan Muda Tags: Development & Aid Economy & Trade Food Security and Nutrition Food Sustainability Global Headlines Health Humanitarian Emergencies Poverty & SDGs TerraViva United Nations Source Type: news

Benefits of prolonged infusion of beta-lactam antibiotics in patients with sepsis: personal perspectives
INTRODUCTION: In the current era of relatively scarce antibiotic production and significant levels of antimicrobial resistance, optimization of pharmacokinetics and pharmacodynamics of antibiotic therapy is mandatory. Prolonged infusion of beta-lactam antibiotics in comparison to the intermittent infusion has the theoretical advantage of better patient outcomes. Apparently, conflicting data in the literature possibly underestimate the benefits of prolonged infusion of antibiotic treatment. AREAS COVERED: We provide our perspective on the subject based on our experience and by critically evaluating literature data. EXPERT O...
Source: Current Awareness Service for Health (CASH) - July 1, 2020 Category: Consumer Health News Source Type: news

Detection of Ciprofloxacin-Resistant, β-Lactamase-Producing Neisseria meningitidis Serogroup Y Isolates - United States, 2019-2020
This report describes a novel, antibiotic-resistant strain of Neisseria meningitidis bacteria that has been detected in the United States. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - June 18, 2020 Category: American Health Tags: Antibiotic and Antimicrobial Resistance MMWR Morbidity & Mortality Weekly Report Meningococcal Disease Source Type: news

Understanding Antimicrobial Resistance Understanding Antimicrobial Resistance
Which bacteria are considered the most threatening resistant organisms in the U.S.? Learn about their mechanisms of resistance and new antibiotics to combat them in this review.U.S. Pharmacist (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 12, 2020 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Under-investigated plants from the myrtle family found to have antibacterial activity
(Natural News) Antimicrobial resistance (AMR) continues to be a global health threat. As microbial pathogens develop new resistance mechanisms, common infectious diseases become difficult to treat. As a consequence, they also become more dangerous. For instance, the World Health Organization (WHO) reports that in 2014, nearly half-a-million people died from tuberculosis, which was caused by a... (Source: NaturalNews.com)
Source: NaturalNews.com - June 4, 2020 Category: Consumer Health News Source Type: news

U.S. FDA Approves New Pediatric Formulation of SIRTURO ® (bedaquiline) as Part of Combination Therapy to Treat Children with Pulmonary Multidrug-Resistant Tuberculosis
NEW BRUNSWICK, NJ, May 27, 2020 — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted approval for a new pediatric formulation of SIRTURO® (bedaquiline). SIRTURO® is now indicated for use as part of combination therapy in the treatment of adult and pediatric patients (5 years and older and weighing at least 15 kg) with pulmonary multidrug-resistant tuberculosis (MDR‑TB). In the U.S., the medicine should be reserved for use when an effective treatment regimen cannot otherwise be provided. This indication received acceler...
Source: Johnson and Johnson - May 27, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Pharmacokinetic and pharmacodynamic considerations in antimicrobial therapy for sepsis
Introduction: Antimicrobial dose optimization for the treatment of sepsis remains challenging because of dynamic pharmacokinetic alterations and physiological/pathological responses of the host. Subtherapeutic plasma levels of antimicrobials are commonly observed in patients with sepsis, which potentially leads to both treatment failure and emergence of antimicrobial resistance. The knowledge of antimicrobial pharmacokinetics and pharmacodynamics is helpful in order to tailor antimicrobial dosing strategies. Areas covered: This narrative review summarizes pharmacokinetic alterations of antimicrobial agents and provides use...
Source: Current Awareness Service for Health (CASH) - May 6, 2020 Category: Consumer Health News Source Type: news

Coronavirus lessons for the fight against ‘superbugs’
The world needs to act now to avert the threat from antimicrobial resistance (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 5, 2020 Category: Pharmaceuticals Source Type: news

New drug formulation could treat Candida infections
With antimicrobial resistance (AMR) increasing around the world, new research led by the University of Bristol has shown a new drug formulation could possibly be used in antifungal treatments against Candida infections. (Source: University of Bristol news)
Source: University of Bristol news - April 28, 2020 Category: Universities & Medical Training Tags: Health, International, Research; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Dental School; Press Release Source Type: news

Aquaculture at the crossroads of global warming and antimicrobial resistance
(Institut de recherche pour le d é veloppement) Antimicrobial resistance is responsible for some 700 000 deaths each year worldwide. In relation to this phenomenon, a team of researchers from IRD and CIRAD have raised the alarm regarding the development of antimicrobial-resistant bacteria in aquaculture, which is affecting fish production and human health worldwide. Their study, published in Nature Communications on ... April 2020, established for the first time a link between global warming and an increased risk of antimicrobial resistance, and warned against inappropriate use of antibiotics. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 20, 2020 Category: Biology Source Type: news

We Need to Rethink Our Food System to Prevent the Next Pandemic
Once a dangerous new pathogen is out, as we are seeing, it can be difficult if not impossible to prevent it going global. One as contagious as SARS-CoV-2 has the potential to infect the whole of humanity. Eighty per cent of cases may be benign, but with such a large pool of susceptible hosts, the numbers who experience severe illness and die can still be shockingly high. So the only sensible answer to the question, how do we stop this from happening again, is: by doing all we can to prevent such pathogens infecting humans in the first place. And that means taking a long, hard look at our relationship with the natural world...
Source: TIME: Health - April 13, 2020 Category: Consumer Health News Authors: Laura Spinney Tags: Uncategorized COVID-19 Source Type: news

NHS could save £ 89 million and further fight against antimicrobial resistance
(Taylor& Francis Group) The NHS could save up to £ 89 million a year on unnecessary prescriptions for antibiotics, and further its efforts in the fight against antimicrobial resistance -- if it was to comprehensively introduce already available and accurate point-of-care (POCTs) diagnostic tests. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - April 7, 2020 Category: International Medicine & Public Health Source Type: news

Merck ’s Dr. Julie Gerberding on the threat of antimicrobial resistance and COVID-19
As America ’s biopharmaceutical companies workaround the clock to combat COVID-19, a disease caused by a novel strain of coronavirus, now is an important time to consider how we can prepare for the next public health emergency: Antimicrobial resistance (AMR). AMR occurs when microorganisms such as bacteria, viruses, fungi and parasites change in ways that make the medications used to cure the infections they cause ineffective. According to the Centers for Disease Control and Prevention (CDC), more than 2.8 million antibiotic-resistant infections occur in the U.S. each year, and more than 35,000 people die as a r...
Source: The Catalyst - April 6, 2020 Category: Pharmaceuticals Tags: Research and Development PhRMA Member Company Infectious Diseases Coronavirus Source Type: news

Antimicrobial Resistance (AMR) Reporting Protocol 2020: European Antimicrobial Resistance Surveillance Network (EARS-Net) Surveillance Data for 2019
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 3/31/2020. This 41-page reporting protocol is for the 2020 data call for antimicrobial resistance (AMR) surveillance data collected by the European Antimicrobial Resistance Surveillance Network (EARS-Net) for 2019. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - March 31, 2020 Category: International Medicine & Public Health Source Type: news

World Health Organization Antimicrobial Expert Explains Transmission Of Coronavirus
NPR's Mary Louise Kelly speaks with Dr. Hanan Balkhy, assistant director-general for antimicrobial resistance at the World Health Organization, about the transmissibility of the coronavirus. (Source: NPR Health and Science)
Source: NPR Health and Science - March 30, 2020 Category: Consumer Health News Source Type: news

CDC Ranks Two More Drug-Resistant Microbes as ‘Urgent Threat’ to Americans; Clinical Laboratories Are Advised to Increase Awareness of Antimicrobial Resistance
In a separate study, HHS finds a 40% increase in sepsis cases, as more patients succumb to infections without effective antibiotics and antimicrobial drugs Given the drastic steps being taken to slow the spread of the Coronavirus in America, it’s easy to forget that significant numbers of patients die each year due to antibiotic-resistant bacteria […] (Source: Dark Daily)
Source: Dark Daily - March 20, 2020 Category: Laboratory Medicine Authors: Jude Tags: Laboratory Management and Operations Laboratory News Laboratory Operations Laboratory Pathology Laboratory Testing Management & Operations News From Dark Daily anatomic pathology antibiotic resistance c. auris C. difficile Candida au Source Type: news

Notes from the Field: Carbapenemase-Producing Klebsiella pneumoniae in a Ventilator-Capable Skilled Nursing Facility - Maricopa County, Arizona, July-November 2018
Maricopa County Department of Public Health in Arizona investigated a cluster of two genetically similar antibiotic-resistant bacterial infections in residents of the ventilator-capable unit of a skilled nursing facility to look for health care-associated bacterial spread. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - March 12, 2020 Category: American Health Tags: Antibiotic and Antimicrobial Resistance Carbapenem Resistant Enterobacteriaceae (CRE) MMWR Morbidity & Mortality Weekly Report Source Type: news

Antimicrobial resistance and infections
This e-learning programme aims to help community pharmacy staff understand the connection between antibiotic use and antibiotic resistance and identify their role in optimising antibiotic use in the general population who visit their pharmacy. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 12, 2020 Category: Consumer Health News Source Type: news

Malaria triple therapies ‘effective and safe’
First trials show improved outcomes in countries with multi-drug resistant malaria. Related items fromOnMedica Single-dose malaria drug eliminates parasite from liver NI launches ‘One Health’ plan to tackle antimicrobial resistance ‘Conclusive evidence’ that antiretroviral therapy wards off HIV transmission HPV programme linked to dramatic fall in cervical disease £30 million to tackle antimicrobial resistance (Source: OnMedica Latest News)
Source: OnMedica Latest News - March 12, 2020 Category: UK Health Source Type: news

NHS battles coronavirus fake news
Package of measures launched Related items fromOnMedica Should we recognise obesity as a disease? NI launches ‘One Health’ plan to tackle antimicrobial resistance Higher daily nut consumption linked to lower weight gain Midwives demand ‘equivalence’ in prison perinatal care NHS must improve access to screening to save lives (Source: OnMedica Latest News)
Source: OnMedica Latest News - March 10, 2020 Category: UK Health Source Type: news

IVI and DTU to strengthen external quality assurance in the face of rising AMR in Asia
(International Vaccine Institute) The International Vaccine Institute (IVI) and the Technical University of Denmark's (DTU) National Food Institute announced today a joint effort to strengthen external quality assurance programs for diagnostic laboratories in Asia to confront the challenges of rising antimicrobial resistance (AMR) in the region. The partnership was established following the award of a Fleming Fund Regional Grant with DTU as the lead grantee and will carry out the project under the name EQASIA (Strengthening External Quality Assurance for AMR in Asia). (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - March 5, 2020 Category: International Medicine & Public Health Source Type: news

Government plan for tackling coronavirus published
Retired NHS staff could be called back to help out if service cannot cope as cases escalate and staff call in sick Related items fromOnMedica Going Viral Unhealthy ambition £30 million to tackle antimicrobial resistance NHS announces wider surveillance testing for COVID-19 ‘Big Food’ a major driver for obesity pandemic (Source: OnMedica Latest News)
Source: OnMedica Latest News - March 4, 2020 Category: UK Health Source Type: news

First-of-its-kind global collaboration launched to develop transformative treatment regimens for tuberculosis
27 February 2020 – Today a consortium of philanthropic, non-profit and private sector organizations launched a collaboration that aims to accelerate the development of novel “pan-TB” drug regimens for the treatment of tuberculosis (TB) that are ready for phase 3 development. The regimens will be designed to have little to no drug resistance and an acceptable safety profile, and be better-tolerated, shorter in duration and simpler to use than existing options. Such regimens are intended to be a central component of efforts to address the current complexities and challenges of TB treatment.The members of th...
Source: Johnson and Johnson - February 28, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

NHS announces wider surveillance testing for COVID-19
Some patients in selected hospital intensive care units and GP surgeries will be tested to check for underground spread of the virus Related items fromOnMedica Going Viral G8 must tackle health inequality, says Bill Gates and WHO UK government pledges £20 million to help develop coronavirus vaccine £30 million to tackle antimicrobial resistance Call for health systems to be ‘migration aware’ (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 27, 2020 Category: UK Health Source Type: news

Duke researchers: Fight antibiotic resistance through Medicare
Researchers at Duke University say that if the country plans to properly address the growing threat of antibiotic resistance it will require a fundamental change in reimbursements for drugmakers. According to a new report in Health Affairs by researchers at the university's Margolis Center for Health Policy, the implementation of a "subscription model" would increase the development and ability of antibiotics necessary to combat the rising antimicrobial resistance (AMR) seen around the glo be. In… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 20, 2020 Category: Pharmaceuticals Authors: Seth Thomas Gulledge Source Type: news

QuickStats: Percentage of Emergency Department Visits for Acute Viral Upper Respiratory Tract Infection at Which an Antimicrobial Was Given or Prescribed, by Age - United States, 2010-2017
From 2010-2013 to 2014-2017, the percentage of emergency department visits for acute viral upper respiratory tract infection that had an antimicrobial given or prescribed decreased from 23.4% to 17.6%. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - February 13, 2020 Category: American Health Tags: Antibiotic and Antimicrobial Resistance Emergency Department Use Emergency Department Visits MMWR Morbidity & Mortality Weekly Report Respiratory Illness Source Type: news

Notes from the Field: Carbapenem-resistant Klebsiella pneumoniae with mcr-1 Gene Identified in a Hospitalized Patient - Wyoming, January 2019
In December of 2018, Wyoming identified the state's first case of carbapenem-resistant Enterobacteriaceae (CRE) containing mcr-1, which is a gene that can make bacteria resistant to colistin, a drug that can be the last resort for some multidrug-resistant infections like CRE. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - February 13, 2020 Category: American Health Tags: Antibiotic and Antimicrobial Resistance Carbapenem Resistant Enterobacteriaceae (CRE) MMWR Morbidity & Mortality Weekly Report Carbapenem Resistant Enterobacteriaceae CRE Source Type: news

The Lancet Infectious Diseases Commission on antimicrobial resistance: 6 years later
Amongst other points, this update highlights that, except for in a few leading countries, antimicrobial resistance has not captured the sustained focus of national leaders and country-level actors, including care providers. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 13, 2020 Category: Consumer Health News Source Type: news

More healthcare professionals to be allowed to prescribe
The Medicines and Medical Devices Bill will expand number of prescribers of low-risk medicines to reduce GP workload Related items fromOnMedica Variations in uptake of prescribing guidance impact on patients Antibiotic scrip rates lower in CAM-trained practices Pharmacists could offer high-dose statins direct to patients Clinicians need better options if we are to stop over-medication NI launches ‘One Health’ plan to tackle antimicrobial resistance (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 13, 2020 Category: UK Health Source Type: news

Antibiotics discovered that kill bacteria in a new way: McMaster
(McMaster University) A new group of antibiotics with a unique approach to attacking bacteria has been discovered, making it a promising clinical candidate in the fight against antimicrobial resistance. The newly-found corbomycin and the lesser-known complestatin have a never-before-seen way to kill bacteria, which is achieved by blocking the function of the bacterial cell wall. The discovery comes from a family of antibiotics called glycopeptides that are produced by soil bacteria. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 12, 2020 Category: Infectious Diseases Source Type: news

Who will lead the global surveillance of antimicrobial resistance via sewage?
(Technical University of Denmark) In the journal Science, a DTU professor calls for someone to carry on a global surveillance of antimicrobial resistance and infectious diseases via sewage. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 10, 2020 Category: Infectious Diseases Source Type: news

Using sewage for surveillance of antimicrobial resistance
(Source: ScienceNOW)
Source: ScienceNOW - February 6, 2020 Category: Science Authors: Aarestrup, F. M., Woolhouse, M. E. J. Tags: Medicine, Diseases, Microbiology p-forum Source Type: news

Analyzing the differences in antibiotic resistance between the gut and mouth microbiome
(King's College London) The threat of antimicrobial resistance to medication is a global health issue. Recent years have seen a surge in our awareness of resistance genes; and as a result of the prevalence of these genes, antibiotics are becoming less effective at treating microbial infections, such as TB and gonorrhea. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 4, 2020 Category: International Medicine & Public Health Source Type: news

WHO Warns About Lack of R & D on Antimicrobial Resistance
Two recent reports by the World Health Organization (WHO) have found that the pipeline for new antibiotic agents is weak and that government intervention is required to address the global threat of drug-resistant microbes. “Declining private investment and lack of innovation in the development of new antibiotics are undermining efforts to combat drug-resistant infections,” stated WHO. According to a 2019 United Nations report, 700,000 deaths occur annually as a result of antimicrobial resistant infections, and this number is estimated to rise to 10 million by 2050 if the problem is not addressed. According to...
Source: Public Policy Reports - February 4, 2020 Category: Biology Authors: AIBS Source Type: news

European Union Summary Report on Antimicrobial Resistance in Zoonotic and Indicator Bacteria from Humans, Animals and Food in 2017/2018
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 1/31/2020. Salmonella and campylobacter are becoming increasingly resistant to ciprofloxacin, one of the antibiotics of choice for treating infections caused by these bacteria. That conclusion is part of this 166-page report on antimicrobial resistance in zoonoses, released with the European Food Safety Authority (EFSA), which also presents some positive trends in the animal sector and includes key outcome indicators that will help European Union Member States assess their progress in reducing the use of antimicrobials and combat...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - January 31, 2020 Category: International Medicine & Public Health Source Type: news

Tests for coronavirus conducted on 14 people in UK
WHO decides against declaring coronavirus an international public health emergency for the present Related items fromOnMedica UK measures in place to reduce the spread of coronavirus Should we have compulsory measles vaccination at school entry? £30 million to tackle antimicrobial resistance England to get a swine flu 'tzar' Health Secretary announces 'Don't panic' over swine flu, doc leaders urge (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 24, 2020 Category: UK Health Source Type: news

' Weak antibiotic pipeline' poses threat to antimicrobial resistance (AMR) fight
Two reports from the World Health Organisation highlight concern over the lack of investment. It is stated that the 60 products in development (50 antibiotics and 10 biologics) bring little benefit over existing treatments and very few target gram-negative bacteria. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 23, 2020 Category: Consumer Health News Source Type: news

Implementing a toolkit for the prevention, management and control of carbapenemase-producing Enterobacteriaceae in English acute hospitals trusts: a qualitative evaluation
Antimicrobial resistance is an increasing problem in hospitals world-wide. Following other countries, English hospitals experienced outbreaks of carbapenemase-producing Enterobacteriaceae (CPE), a bacterial infection commonly resistant to last resort antibiotics. One way to improve CPE prevention, management and control is the production of guidelines, such as the CPE toolkit published by Public Health England in December 2013. The aim of this research was to investigate the implementation of the CPE toolkit and to identify barriers and facilitators to inform future policies. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 23, 2020 Category: Consumer Health News Source Type: news

Ghana: Antibiotics Use and Effects On Gut Flora
[Ghanaian Times] There is concern about the effects of irrational use of antibiotics. This is not only because of the issue of antimicrobial resistance but importantly about the effect of antibiotics on the gut microbiota. The digestive tract especially the large intestine is the habitat for millions of microbes living in concert with several functions of the body. Antibiotics have been very useful in treating and controlling infections with positive impact of standard of living. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 22, 2020 Category: African Health Source Type: news

Impact of vaccines on antimicrobial resistance
This review shows how vaccines can decrease AMR by preventing bacterial and viral infections, thereby reducing the use/misuse of antibiotics, and by preventing antibiotic-resistant infections. Vaccines are less likely to induce resistance. Some future uses and developments of vaccines are also discussed. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 16, 2020 Category: Consumer Health News Source Type: news